Supplementation of crocin on cognitive impairment and oxidative stress in multiple sclerosis patients: A double-blind randomized clinical trial
نویسندگان
1 دانشگاه سمنان
2 دانشگاه شهید باهنر کرمان
3 دانشگاه هنر
4 دانشگاه آزاد اسلامی
5 دانشگاه صنعتی امیرکبیر
6 دانشگاه فردوسی مشهد
doi
10.48307/iahsj.2024.420035.1073چکیده
Objectives: Multiple sclerosis (MS) is a disorder that primarily affects the central nervous system, leading to demyelination. Despite extensive research, specific treatments for cognitive disorders in MS patients remain lacking. Given the antioxidant properties of saffron and its potential to prevent neuronal degeneration and enhance cognition, we conducted a study to investigate the effects of crocin, a bioactive compound found in saffron, on oxidative stress biomarkers and cognitive factors in MS patients. Methods: This interventional study was conducted at Beheshti Hospital in Kashan in 2022. MS patients were randomized into two groups: one group received 15 mg crocin tablets twice daily (n = 25; 30 mg/day), while the other group received a placebo (n = 20) for 8 weeks. The MACFIMS questionnaires were administered, and blood samples were collected at baseline and at week 8 following the intervention. Results: The results indicated no significant differences between the crocin and placebo groups across all cognitive questionnaires and tests, with the exception of the Persian Adult Reading Test (PART) and the Nine Hole Peg Test (9HPT) for the right hand, as determined by the analysis of covariance (ANCOVA) test (P < 0.05). Biochemical analyses showed no significant differences between the two groups regarding serum malondialdehyde (MDA), total glutathione (GSH), and plasma total antioxidant capacity (TAC) after 8 weeks of intervention (both P ≥ 0.05). Conclusion: Our findings suggest that crocin supplementation for 8 weeks may not be effective in improving cognitive factors in MS patients, with the exception of two measures. Furthermore, crocin supplementation did not demonstrate any beneficial effects on oxidative stress markers in this population. Future clinical studies with higher doses and longer durations of crocin supplementation are recommended to further assess its impact on oxidative biomarkers and cognitive factors in MS patients.